Jae-Hwan Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jae-Hwan Choi has a total of 162 co-authors. Here are the top co-authors by number of shared publications:
Eun Hye Oh
Department of Neurology, Seo Il Medical Group Clinic, Busan, South Korea
30 shared publicationsKwang-Dong Choi
Department of Neurology, Pusan National University Hospital, Pusan National University School of Medicine and Biomedical Research Institute, Busan, South Korea
27 shared publicationsSeo Young Choi
Department of Neurology, Pusan National University Hospital, Pusan National University School of Medicine and Biomedical Research Institute, Busan, South Korea
16 shared publicationsHyun Sung Kim
Department of Neurology, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University School of Medicine, Pusan National University Yangsan Hospital, Yangsan, South Korea
10 shared publications- Kwang-Dong Choi
Department of Neurology, Pusan National University Hospital, Pusan National University School of Medicine and Biomedical Research Institute, Busan, South Korea
10 shared publications Seo-Young Choi
Department of Neurology, Pusan National University Hospital, Pusan National University School of Medicine and Biomedical Research Institute, Busan, South Korea
10 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 25 (3) , 83-90
Otolin-1 and otoconin-90 as serum biomarkers for benign paroxysmal positional vertigo: a narrative review
Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder, arising from degeneration and displacement of otoconia from the utricular macula into the semicircular canals. Although diagnosis relies on clinical history and provocative positional maneuvers, it may be challenging when positional nystagmus is subtle or absent or when positional testing cannot be adequately performed. Otolin-1 and otoconin-90 (OC90), the two principal structural proteins of the otoconial matrix, can cross the blood-labyrinth barrier and can be detected and quantified in peripheral serum, making them candidate biomarkers of otoconial degeneration. This narrative review summarizes current evidence for otolin-1 and OC90 as diagnostic and prognostic biomarkers in BPPV. Across multiple case-control studies and one meta-analysis, serum otolin-1 has been consistently elevated in patients with BPPV compared with healthy controls, and may also be associated with disease severity and recurrence. In contrast, findings for OC90 have been inconsistent, with studies reporting increased, decreased, or unchanged levels in BPPV relative to controls. Despite these promising findings, substantial heterogeneity in laboratory methods, potential biological confounders, inconsistent timing of blood sampling, and the lack of comparisons with other vestibular disorders currently limit their clinical applicability. Standardized assays and well-designed prospective studies incorporating serial measurements and appropriate disease-control groups are needed to determine whether these proteins can serve as reliable and specific biomarkers for BPPV.
- 15 September 2026
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 25 (3) , 83-90
Open AccessOtolin-1 and otoconin-90 as serum biomarkers for benign paroxysmal positional vertigo: a narrative review
Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder, arising from degeneration and displacement of otoconia from the utricular macula into the semicircular canals. Although diagnosis relies on clinical history and provocative positional maneuvers, it may be challenging when positional nystagmus is subtle or absent or when positional testing cannot be adequately performed. Otolin-1 and otoconin-90 (OC90), the two principal structural proteins of the otoconial matrix, can cross the blood-labyrinth barrier and can be detected and quantified in peripheral serum, making them candidate biomarkers of otoconial degeneration. This narrative review summarizes current evidence for otolin-1 and OC90 as diagnostic and prognostic biomarkers in BPPV. Across multiple case-control studies and one meta-analysis, serum otolin-1 has been consistently elevated in patients with BPPV compared with healthy controls, and may also be associated with disease severity and recurrence. In contrast, findings for OC90 have been inconsistent, with studies reporting increased, decreased, or unchanged levels in BPPV relative to controls. Despite these promising findings, substantial heterogeneity in laboratory methods, potential biological confounders, inconsistent timing of blood sampling, and the lack of comparisons with other vestibular disorders currently limit their clinical applicability. Standardized assays and well-designed prospective studies incorporating serial measurements and appropriate disease-control groups are needed to determine whether these proteins can serve as reliable and specific biomarkers for BPPV.
- 17 July 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (8) , 639
Temporal enhancement patterns on 3D-FLAIR MRI in labyrinthine infarction
Background Inner ear enhancement on contrast-enhanced three-dimensional fluid-attenuated inversion recovery (3D-FLAIR) MRI reflects disruption of the blood–labyrinth barrier (BLB) and has been reported in several audiovestibular disorders. However, the temporal enhancement pattern in labyrinthine infarction remains poorly characterized. Methods We investigated time-dependent enhancement patterns on 3D-FLAIR MRI in four patients with labyrinthine infarction secondary to anterior inferior cerebellar artery infarction. All patients underwent comprehensive neuro-otological evaluation and contrast-enhanced inner ear MRI. Axial 3D-FLAIR images were obtained at three time points: pre-contrast, 10 min, and 4 h after gadolinium administration. Enhancement patterns were compared with those observed in 37 patients with non-vascular audiovestibular disorders, including sudden sensorineural hearing loss with vertigo ( n = 3), Ménière’s disease (n = 9), recurrent vestibulopathy (n = 14), acute unilateral vestibulopathy (n = 11), who underwent the same imaging protocol. Results All four patients with labyrinthine infarction demonstrated ipsilesional enhancement of both the cochlea and vestibule on 4-hour delayed images. Two patients also showed early enhancement confined to the cochlea on 10-minute images. By contrast, only 8 of 37 patients (22%) with non-vascular audiovestibular disorders demonstrated enhancement, which was predominantly observed on 4-hour delayed images but not detected on 10-minute images. Conclusions These findings suggest that 4-hour delayed enhancement is a consistent imaging feature of labyrinthine infarction, whereas early (10-minute) enhancement may occur in a subset of patients and may provide insight into the temporal evolution of BLB disruption following ischemic injury.
- 17 July 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (8) , 639
Temporal enhancement patterns on 3D-FLAIR MRI in labyrinthine infarction
Background Inner ear enhancement on contrast-enhanced three-dimensional fluid-attenuated inversion recovery (3D-FLAIR) MRI reflects disruption of the blood–labyrinth barrier (BLB) and has been reported in several audiovestibular disorders. However, the temporal enhancement pattern in labyrinthine infarction remains poorly characterized. Methods We investigated time-dependent enhancement patterns on 3D-FLAIR MRI in four patients with labyrinthine infarction secondary to anterior inferior cerebellar artery infarction. All patients underwent comprehensive neuro-otological evaluation and contrast-enhanced inner ear MRI. Axial 3D-FLAIR images were obtained at three time points: pre-contrast, 10 min, and 4 h after gadolinium administration. Enhancement patterns were compared with those observed in 37 patients with non-vascular audiovestibular disorders, including sudden sensorineural hearing loss with vertigo ( n = 3), Ménière’s disease (n = 9), recurrent vestibulopathy (n = 14), acute unilateral vestibulopathy (n = 11), who underwent the same imaging protocol. Results All four patients with labyrinthine infarction demonstrated ipsilesional enhancement of both the cochlea and vestibule on 4-hour delayed images. Two patients also showed early enhancement confined to the cochlea on 10-minute images. By contrast, only 8 of 37 patients (22%) with non-vascular audiovestibular disorders demonstrated enhancement, which was predominantly observed on 4-hour delayed images but not detected on 10-minute images. Conclusions These findings suggest that 4-hour delayed enhancement is a consistent imaging feature of labyrinthine infarction, whereas early (10-minute) enhancement may occur in a subset of patients and may provide insight into the temporal evolution of BLB disruption following ischemic injury.
- Open Access
- 15 June 2026
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 25 (2) , 67-71
Atypical Cogan syndrome in a child with prior immunoglobulin A vasculitis: a case report
Cogan syndrome is a rare immune-mediated disorder characterized by ocular inflammation and audiovestibular dysfunction. Pediatric cases are uncommon and often present with nonspecific systemic inflammatory symptoms, leading to diagnostic delay. We report a 12-year-old girl with acute vertigo, bilateral hearing loss, and prior iridocyclitis following a febrile illness and polyarthralgia, with a history of immunoglobulin A vasculitis (Henoch-Schönlein purpura). Neuro-otological evaluations revealed spontaneous left-beating nystagmus, positive head impulse to the right side, and bilateral sensorineural hearing loss. Extensive autoimmune, infectious, and imaging evaluations were unremarkable. Based on the coexistence of ocular inflammation and audiovestibular dysfunction, atypical Cogan syndrome was diagnosed. Audiovestibular symptoms resolved after intravenous methylprednisolone pulse therapy and subsequent treatment with oral prednisolone and methotrexate. This case highlights the diagnostic challenge of pediatric atypical Cogan syndrome and the importance of early recognition and prompt treatment.
- 15 June 2026
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 25 (2) , 67-71
Open AccessAtypical Cogan syndrome in a child with prior immunoglobulin A vasculitis: a case report
Cogan syndrome is a rare immune-mediated disorder characterized by ocular inflammation and audiovestibular dysfunction. Pediatric cases are uncommon and often present with nonspecific systemic inflammatory symptoms, leading to diagnostic delay. We report a 12-year-old girl with acute vertigo, bilateral hearing loss, and prior iridocyclitis following a febrile illness and polyarthralgia, with a history of immunoglobulin A vasculitis (Henoch-Schönlein purpura). Neuro-otological evaluations revealed spontaneous left-beating nystagmus, positive head impulse to the right side, and bilateral sensorineural hearing loss. Extensive autoimmune, infectious, and imaging evaluations were unremarkable. Based on the coexistence of ocular inflammation and audiovestibular dysfunction, atypical Cogan syndrome was diagnosed. Audiovestibular symptoms resolved after intravenous methylprednisolone pulse therapy and subsequent treatment with oral prednisolone and methotrexate. This case highlights the diagnostic challenge of pediatric atypical Cogan syndrome and the importance of early recognition and prompt treatment.
- 9 June 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (11) , e218124
Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of Korea
- 9 June 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (11) , e218124
Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of Korea
- 14 April 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (7) , e214792
Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the Republic of Korea
To provide the clinically validated, nationwide estimates of multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in Korea, and to describe their relative proportions. From January to March 2025, 47 referral hospitals participating in a nationwide hospital-based registry identified actively followed patients with MS, NMOSD, or MOGAD. Diagnoses followed international criteria, and antibody status was confirmed using validated CBAs. Actively followed patients had ≥1 outpatient visit in the prior 6 months. Centers provided demographics, treatments, and Expanded Disability Status Scale. Prevalence used national population data. A total of 4,196 patients were identified, 1,799 MS, 1,616 NMOSD, and 781 MOGAD (ratio 2.3:2.1:1). Mean age at onset was 33.4 ± 12.0 years for MS, 42.7 ± 14.7 for NMOSD, and 41.7 ± 17.8 for MOGAD, and the female-to-male ratios were 2.2:1 for MS, 5.1:1 for NMOSD (6.5:1 in aquaporin-4-IgG positive cases), and 1.5:1 for MOGAD. Crude prevalence estimates were 3.48, 3.13, and 1.51 per 100,000, respectively. This nationwide registry demonstrates a distinctive Korean CNS inflammatory demyelinating disease profile, with a relatively higher proportion of NMOSD and MOGAD reflecting the low prevalence of MS in East Asia.
- 14 April 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (7) , e214792
Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the Republic of Korea
To provide the clinically validated, nationwide estimates of multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in Korea, and to describe their relative proportions. From January to March 2025, 47 referral hospitals participating in a nationwide hospital-based registry identified actively followed patients with MS, NMOSD, or MOGAD. Diagnoses followed international criteria, and antibody status was confirmed using validated CBAs. Actively followed patients had ≥1 outpatient visit in the prior 6 months. Centers provided demographics, treatments, and Expanded Disability Status Scale. Prevalence used national population data. A total of 4,196 patients were identified, 1,799 MS, 1,616 NMOSD, and 781 MOGAD (ratio 2.3:2.1:1). Mean age at onset was 33.4 ± 12.0 years for MS, 42.7 ± 14.7 for NMOSD, and 41.7 ± 17.8 for MOGAD, and the female-to-male ratios were 2.2:1 for MS, 5.1:1 for NMOSD (6.5:1 in aquaporin-4-IgG positive cases), and 1.5:1 for MOGAD. Crude prevalence estimates were 3.48, 3.13, and 1.51 per 100,000, respectively. This nationwide registry demonstrates a distinctive Korean CNS inflammatory demyelinating disease profile, with a relatively higher proportion of NMOSD and MOGAD reflecting the low prevalence of MS in East Asia.
- 7 March 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (4)
Neurosyphilis presenting as ocular motor nerve palsy: two cases and a systematic literature review
- 7 March 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (4)
Neurosyphilis presenting as ocular motor nerve palsy: two cases and a systematic literature review
- 18 January 2026
- Published by SAGE Publications in Journal of Vestibular Research
- Vol. 36 (6) , 452-461
Identification of blood-based inflammatory biomarkers for vestibular neuritis using a proximity extension assay
Objective: The present study aimed to identify blood-based inflammatory biomarkers that would help investigate the underlying pathogenesis in vestibular neuritis (VN) using a proximity extension assay (PEA). Methods: In this single-center prospective study, we enrolled both a cross-sectional (acute VN vs normal controls) and a longitudinal (acute phase vs recovery phase) cohorts. We quantified 92 plasma inflammatory proteins using the Olink PEA and identified differentially expressed proteins (DEPs) in each cohort using t-tests. The clinical utility and predictive value of each DEP were evaluated using the Pearson correlation test and receiver operating characteristic (ROC) curve analysis, respectively. Results: In the cross-sectional cohort, there were 17 DEPs identified between acute VN ( n = 35) and normal controls ( n = 35), of which Flt3L was the only downregulated DEP that showed longitudinal changes congruent with clinical disease activity in the longitudinal cohort ( n = 18). The correlation analysis revealed that the expression level of CXCL5 was significantly related to the absolute gain and gain asymmetry of the horizontal vestibulo-ocular reflex, while five DEPs (OSM, Flt3L, IFN-γ, MCP-1, and uPA) were negatively correlated with the hospitalization period. ROC curves showed that CXCL1 and Flt3L were upregulated and downregulated DEPs with high predictive values, respectively. Conclusions: This study shows that the high-throughput PEA technology can be used to identify blood-based inflammatory biomarkers for VN. Our findings highlight the potential value of Flt3L and CXCL1/CXCL5 as objective VN markers that may correlate with disease activity.
- 18 January 2026
- Published by SAGE Publications in Journal of Vestibular Research
- Vol. 36 (6) , 452-461
Identification of blood-based inflammatory biomarkers for vestibular neuritis using a proximity extension assay
Objective: The present study aimed to identify blood-based inflammatory biomarkers that would help investigate the underlying pathogenesis in vestibular neuritis (VN) using a proximity extension assay (PEA). Methods: In this single-center prospective study, we enrolled both a cross-sectional (acute VN vs normal controls) and a longitudinal (acute phase vs recovery phase) cohorts. We quantified 92 plasma inflammatory proteins using the Olink PEA and identified differentially expressed proteins (DEPs) in each cohort using t-tests. The clinical utility and predictive value of each DEP were evaluated using the Pearson correlation test and receiver operating characteristic (ROC) curve analysis, respectively. Results: In the cross-sectional cohort, there were 17 DEPs identified between acute VN ( n = 35) and normal controls ( n = 35), of which Flt3L was the only downregulated DEP that showed longitudinal changes congruent with clinical disease activity in the longitudinal cohort ( n = 18). The correlation analysis revealed that the expression level of CXCL5 was significantly related to the absolute gain and gain asymmetry of the horizontal vestibulo-ocular reflex, while five DEPs (OSM, Flt3L, IFN-γ, MCP-1, and uPA) were negatively correlated with the hospitalization period. ROC curves showed that CXCL1 and Flt3L were upregulated and downregulated DEPs with high predictive values, respectively. Conclusions: This study shows that the high-throughput PEA technology can be used to identify blood-based inflammatory biomarkers for VN. Our findings highlight the potential value of Flt3L and CXCL1/CXCL5 as objective VN markers that may correlate with disease activity.
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Clinical Neurology
- Vol. 22 (6) , 709-718
Longitudinal Correlation of Vestibular Function With Symptom Improvements in Vestibular Migraine: A Multicenter Prospective Study
Choi SY, et al. J Clin Neurol. 2026 Nov;22(6):709-718. https://doi.org/10.3988/jcn.2026.0262
- 1 January 2026
- Published by XMLink in Journal of Clinical Neurology
- Vol. 22 (6) , 709-718
Open AccessLongitudinal Correlation of Vestibular Function With Symptom Improvements in Vestibular Migraine: A Multicenter Prospective Study
Choi SY, et al. J Clin Neurol. 2026 Nov;22(6):709-718. https://doi.org/10.3988/jcn.2026.0262
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Clinical Neurology
- Vol. 22 (5) , 596-606
Characteristics and Mechanisms of Aperiodic Alternating Nystagmus
Park JY, et al. J Clin Neurol. 2026 Sep;22(5):596-606. https://doi.org/10.3988/jcn.2026.0111
- 1 January 2026
- Published by XMLink in Journal of Clinical Neurology
- Vol. 22 (5) , 596-606
Open AccessCharacteristics and Mechanisms of Aperiodic Alternating Nystagmus
Park JY, et al. J Clin Neurol. 2026 Sep;22(5):596-606. https://doi.org/10.3988/jcn.2026.0111
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Clinical Neurology
- Vol. 22 (4) , 467-476
Neural Correlates of Intellectual Dysfunction in Episodic Ataxia Type 2
Episodic ataxia type 2 (EA2) is characterized by episodes of vertigo and ataxia due to mutations in CACNA1A that encodes the α1A subunit of the P/Q-type voltage-gated calcium channel. This study aimed to identify neural correlates of cognitive dysfunction in EA2 by investigating brain atrophy in these patients and determining the relationships between regional brain volumes and intellectual dysfunction. We recruited 12 patients with EA2 (including 6 males; age=30.5±14.3 years, mean±standard deviation) in 3 university hospitals of South Korea from 2019 to 2023. Regional brain volumes were quantified using voxel-based morphometry and the brainstem-structures feature of FreeSurfer. The results were compared with those for healthy controls. The relationships between regional gray-matter volumes (GMVs) and cognitive function were assessed using voxel-wise multiple regression analyses within the general linear model framework. Brain volumetry revealed a significant decrease in cerebellar volumes, particularly in the vermis (lobules IV, V, and VIII), bilateral flocculi (lobule X), and brainstem. The Full-Scale Intelligence Quotient was positively correlated with the GMVs in the left parahippocampal gyrus, right caudate nucleus, and right cerebellar crus II; the Verbal Comprehension Index was correlated with the GMVs in the bilateral cerebellar crura I and II; and the Processing Speed Index was correlated with the GMV in the right parahippocampal gyrus. Volumetric analyses revealed brain atrophy in patients with EA2 that was correlated with the clinical features observed in this disorder. These findings may further expand the imaging spectrum of disorders associated with CACNA1A mutations, although the identified correlations need to be interpreted with caution.
- 1 January 2026
- Published by XMLink in Journal of Clinical Neurology
- Vol. 22 (4) , 467-476
Open AccessNeural Correlates of Intellectual Dysfunction in Episodic Ataxia Type 2
Episodic ataxia type 2 (EA2) is characterized by episodes of vertigo and ataxia due to mutations in CACNA1A that encodes the α1A subunit of the P/Q-type voltage-gated calcium channel. This study aimed to identify neural correlates of cognitive dysfunction in EA2 by investigating brain atrophy in these patients and determining the relationships between regional brain volumes and intellectual dysfunction. We recruited 12 patients with EA2 (including 6 males; age=30.5±14.3 years, mean±standard deviation) in 3 university hospitals of South Korea from 2019 to 2023. Regional brain volumes were quantified using voxel-based morphometry and the brainstem-structures feature of FreeSurfer. The results were compared with those for healthy controls. The relationships between regional gray-matter volumes (GMVs) and cognitive function were assessed using voxel-wise multiple regression analyses within the general linear model framework. Brain volumetry revealed a significant decrease in cerebellar volumes, particularly in the vermis (lobules IV, V, and VIII), bilateral flocculi (lobule X), and brainstem. The Full-Scale Intelligence Quotient was positively correlated with the GMVs in the left parahippocampal gyrus, right caudate nucleus, and right cerebellar crus II; the Verbal Comprehension Index was correlated with the GMVs in the bilateral cerebellar crura I and II; and the Processing Speed Index was correlated with the GMV in the right parahippocampal gyrus. Volumetric analyses revealed brain atrophy in patients with EA2 that was correlated with the clinical features observed in this disorder. These findings may further expand the imaging spectrum of disorders associated with CACNA1A mutations, although the identified correlations need to be interpreted with caution.